ArticleThe Journal of urology2012

Re: Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Patrick C WalshPubMed ↗Publisher ↗

No numbers read from the abstract.